Fusion Antibodies, a world leading CRO, has today announced that they have successfully completed their 150th Antibody Humanization project as part of their Antibody Engineering offering
Fusion Antibodies are pleased to be attending Antibody Engineering & Therapeutics Asia on 26-28th February 2019 in Tokyo.
Fusion Antibodies is pleased to introduce our unique Antibody Developability by Design platform or ADD™.
Fusion Antibodies will be attending the following events in the first half of 2018. If you are going to be at any of the following events with us today via email at info@fusionantibodies.com and arrange a meeting!
Fusion Antibodies introduces novel Affinity Maturation platform (RAMP™)
Ground Breaking New Saliva Diagnostic Test Set to Help Eliminate Malaria
